PMC:7346000 / 4118-4363 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":34,"end":50},"obj":"Body_part"},{"id":"T3","span":{"begin":45,"end":50},"obj":"Body_part"},{"id":"T4","span":{"begin":63,"end":74},"obj":"Body_part"},{"id":"T5","span":{"begin":109,"end":116},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma66768"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62499"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}

{"project":"LitCovid-PubTator","denotations":[{"id":"144","span":{"begin":124,"end":155},"obj":"Gene"},{"id":"145","span":{"begin":157,"end":161},"obj":"Gene"},{"id":"153","span":{"begin":3,"end":13},"obj":"Species"}],"attributes":[{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"Gene:59272"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"Gene:59272"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T56","span":{"begin":3,"end":11},"obj":"Disease"},{"id":"T57","span":{"begin":98,"end":102},"obj":"Disease"}],"attributes":[{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T23","span":{"begin":34,"end":44},"obj":"http://purl.obolibrary.org/obo/CL_0000066"},{"id":"T24","span":{"begin":45,"end":59},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T25","span":{"begin":174,"end":176},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T26","span":{"begin":195,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T27","span":{"begin":198,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T28","span":{"begin":198,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":60,"end":62},"obj":"Chemical"},{"id":"T21","span":{"begin":109,"end":116},"obj":"Chemical"},{"id":"T22","span":{"begin":124,"end":135},"obj":"Chemical"},{"id":"T23","span":{"begin":198,"end":200},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}

{"project":"2_test","denotations":[{"id":"32599813-16007097-60095066","span":{"begin":174,"end":176},"obj":"16007097"}],"text":"s, SARS-CoV-2 targets and invades epithelial cells and type II pneumocytes through binding of the SARS spike protein to the angiotensin-converting enzyme 2 (ACE2) receptors [11]. Cleavage of the S1/S2 domain by the type 2 transmembrane protease "}